This presentation, free of charge, is designed to help clinicians experienced in working with opioid abusers adopt naltrexone into their practice. Covered topics include: the rationale for using naltrexone to prevent relapse as different from agonist approach, guidelines to select most appropriate patients for treatment with naltrexone, clinical strategies to initiate treatment on outpatient and inpatient basis, safety concerns and management of side effects, and managing common clinical problems emerging during treatment with naltrexone. Clinical decision-making will be illustrated using a case report portraying a complicated treatment initiation.
C4 -This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
C5 - Grey Literature; Opioids & Substance Use CA - 1241.94 KB L3 - 1241.94 KB N2 -This presentation, free of charge, is designed to help clinicians experienced in working with opioid abusers adopt naltrexone into their practice. Covered topics include: the rationale for using naltrexone to prevent relapse as different from agonist approach, guidelines to select most appropriate patients for treatment with naltrexone, clinical strategies to initiate treatment on outpatient and inpatient basis, safety concerns and management of side effects, and managing common clinical problems emerging during treatment with naltrexone. Clinical decision-making will be illustrated using a case report portraying a complicated treatment initiation.
PY - 2014 RN - http://pcssnow.org/wp-content/uploads/2015/02/PCSSMAT-Implementing-Antagonist-with-Case.Bisaga.CME_.pdf T1 - Implementing Antagonist-Based Relapse Prevention Treatment in your Practice TI - Implementing Antagonist-Based Relapse Prevention Treatment in your Practice U1 - Grey Literature; Opioids & Substance Use U4 -This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
U5 - http://pcssnow.org/wp-content/uploads/2015/02/PCSSMAT-Implementing-Antagonist-with-Case.Bisaga.CME_.pdf Y1 - 2014 ER -